Skip to content

DARK STUDY DysbetalipoproteinemiA and atheRoma Risk

Dysbetalipoproteinemia and Atheroma Risk : Assessment of Cardiovascular Risk in Dysbetalipoproteinemic Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01760265
Acronym
DARK
Enrollment
50
Registered
2013-01-04
Start date
2013-01-31
Completion date
2013-06-30
Last updated
2013-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysbetalipoproteinemia

Keywords

dysbetalipoproteinemia, artery calcium score, carotid intima media, ankle brachial index, dysbetalipoproteinemic patients

Brief summary

Dysbetalipoproteinemia (type III, Fredrickson's classification) is a rare metabolic disorder. It results from a defect in the clearance of VLDL and chylomicron remnants due to homozygous APOE2 variants or heterozygous APOE mutations, and there is an elevated plasma cholesterol and triglycerides. As a consequence of the derangements in lipoprotein metabolism, dysbetalipoproteinemia predispose to the premature development of atherosclerosis. However among this population there is heterogeneity in development of cardiovascular complications and the determinants remain unclear actually. The aim of the investigators study is to evaluate the intensity of clinical atherosclerosis, and identify its determinants.

Interventions

None listed

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- apo E gene sequencing in CBE (Centre de Biologie Est / Hospices Civils de Lyon / France) laboratory in Lyon until December 2012

Exclusion criteria

* age \< 40 years * refused participation

Design outcomes

Primary

MeasureTime frameDescription
Computed tomographic measurements for coronary-artery calciumDay one : the coronary calcium score is assessed on the date of measurementComparison with eventual previous examinations.

Secondary

MeasureTime frameDescription
Measurement of carotid intima-media by ultrasonographyDay one : on the date of measurementComparison with eventual previous examinations.
Measurement of ankle brachial indexDay one : on the date of measurementComparison with eventual previous examinations

Countries

France

Contacts

Primary ContactPhilippe MOULIN, Pr
philippe.moulin@chu-lyon.fr4 72 68 13 04

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026